Japan criticised for unsafe drug licencesBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7019.1521a (Published 09 December 1995) Cite this as: BMJ 1995;311:1521
Japan's system for testing and licensing new medicines has come under fire after a spate of fatal reactions to drugs prescribed with official approval. A recent report by the ministry of health and welfare showed that four premature babies died and three became critically ill after being prescribed mefenamic acid to treat their patent ductus arteriosus. Another patient, suffering from idiopathic thrombosis, died after taking danazol, a drug approved for use in the treatment of certain types of infertility.
Critics of the ministry argue that these incidents are typical. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial